THE USE OF A CARBONIC ANHYDRASE INHIBITOR IN THE TREATMENT OF HYPERKALEMIA†

E-ISSN： 1532-5415|4|1|58-64

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.4, Iss.1, 1956-01, pp. : 58-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cyclooxygenase-2 Inhibitor Celecoxib Is a Potent Inhibitor of Human Carbonic Anhydrase II

By Knudsen James Carlsson Uno Hammarström Per Sokol Gerald Cantilena Louis

Inflammation, Vol. 28, Iss. 5, 2004-10 ,pp. : 285-290

Springer Publishing Company

Access to resources Recommend Favorite

Early human studies of a new carbonic anhydrase inhibitor (NSD 3004) with anticonvulsant properties

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 12, Iss. 6, 1971-11 ,pp. : 902-912

John Wiley & Sons Inc

Access to resources Recommend Favorite

Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database

By Lafuma A. Berdeaux G.

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

Antibodies against Carbonic Anhydrase in Patients with Aplastic Anemia

Acta Haematologica, Vol. 128, Iss. 3, 2012-08 ,pp. : 190-194

Karger

Access to resources Recommend Favorite

HYPERKALEMIA

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 2, 1998-02 ,pp. : 252-253

John Wiley & Sons Inc

Access to resources Recommend Favorite